Paolo Paoletti, CEO of GammaDelta Therapeutics celebrated in the 2019 Maserati 100 Innovators of the year award.


GammaDelta Therapeutics has assembled an exceptional team, with experience from all sectors of the biotech and pharma industries. The Board, The Management Team and the Scientific Founders will be responsible for taking all aspects of this ground-breaking research to clinical development.

The Board

Our Board has an impressive portfolio of experience, perfectly placed to enhance the pioneering science and ensure that Gamma Delta Therapeutics will successfully guide this ground-breaking research to market.

Management Team

GammaDelta Therapeutics has recruited the best management team possible. Experts from the pharmaceutical industry with an impeccable pedigree in bringing medicines to market. 

Scientific Founders

Pioneering science is at the heart of the Company, the innovative research completed by the founders relating to the development of novel immunotherapeutics, has the potential to change the way cancer is treated.